Equibles does not estimate personal net worth.
Get an email with a short summary when Pelthos Therapeutics Inc. publishes a filing, an earnings call transcript or a press release.
Get PTHS alertsJohn Gay is recorded as CFO at Pelthos Therapeutics Inc. (PTHS). John Gay has spoken on 2 earnings calls and 1 other investor event across 1 company, most recently for Pelthos Therapeutics Inc. on November 12, 2026. Pelthos Therapeutics Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Pelthos Therapeutics Inc. includes Christian Kopfli (CEO), Francis Knuettel II (CEO, CFO and Chief Accounting Officer), Scott Plesha (CEO and Board Member) and 7 others.
“As Scott and Sai have already touched on, we continue to focus on driving growth for our lead product, Zelsubmi, and look forward to launching Zephi in the first quarter of next year.”
“A complete list of stockholders entitled to vote at this meeting has been available for inspection as required by the bylaws and is accessible during this meeting via the virtual meeting platform.”
“I am pleased to be with you on today's call, and thank you for joining us. As Scott and Cy have already touched on, we continue to see increasing demand for our flagship products, El Sudmi, as demonstrated with our growing pull-through and dispensed units to date.”
Biotechnology · Healthcare
CFO
